Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics

Sergio A. Strejilevich; Ana Palatnik; Rubén Avila; Julián Bustin; Julieta Cassone; Soledad Figueroa; Mariana Gimenez; Gabriel A. De Erausquin

doi:10.1016/j.psychres.2004.10.009

Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics

Sergio A. Strejilevich
, Ana Palatnik
, Rubén Avila
, Julián Bustin
, Julieta Cassone
, Soledad Figueroa
, Mariana Gimenez
, Gabriel A. De Erausquin

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

We compared symptom severity and quality of life (QOL) in schizophrenic patients adequately treated with typical antipsychotics (TAP) or clozapine (CZP). Groups did not differ in symptom severity or QOL. Clozapine caused fewer extrapyramidal symptoms. Negative and extrapyramidal symptoms predicted QOL. Similar outcome in both groups suggests a common ceiling to antipsychotic efficacy.

Original language	English (US)
Pages (from-to)	277-280
Number of pages	4
Journal	Psychiatry Research
Volume	133
Issue number	2-3
DOIs	https://doi.org/10.1016/j.psychres.2004.10.009
State	Published - Feb 28 2005
Externally published	Yes

Keywords

Negative symptoms
Parkinsonism
Treatment outcome

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/j.psychres.2004.10.009

Cite this

@article{292bbf006b364e7c8531853bf4a7b898,

title = "Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics",

abstract = "We compared symptom severity and quality of life (QOL) in schizophrenic patients adequately treated with typical antipsychotics (TAP) or clozapine (CZP). Groups did not differ in symptom severity or QOL. Clozapine caused fewer extrapyramidal symptoms. Negative and extrapyramidal symptoms predicted QOL. Similar outcome in both groups suggests a common ceiling to antipsychotic efficacy.",

keywords = "Negative symptoms, Parkinsonism, Treatment outcome",

author = "Strejilevich, \{Sergio A.\} and Ana Palatnik and Rub{\'e}n Avila and Juli{\'a}n Bustin and Julieta Cassone and Soledad Figueroa and Mariana Gimenez and \{De Erausquin\}, \{Gabriel A.\}",

year = "2005",

month = feb,

day = "28",

doi = "10.1016/j.psychres.2004.10.009",

language = "English (US)",

volume = "133",

pages = "277--280",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

number = "2-3",

}

TY - JOUR

T1 - Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics

AU - Strejilevich, Sergio A.

AU - Palatnik, Ana

AU - Avila, Rubén

AU - Bustin, Julián

AU - Cassone, Julieta

AU - Figueroa, Soledad

AU - Gimenez, Mariana

AU - De Erausquin, Gabriel A.

PY - 2005/2/28

Y1 - 2005/2/28

N2 - We compared symptom severity and quality of life (QOL) in schizophrenic patients adequately treated with typical antipsychotics (TAP) or clozapine (CZP). Groups did not differ in symptom severity or QOL. Clozapine caused fewer extrapyramidal symptoms. Negative and extrapyramidal symptoms predicted QOL. Similar outcome in both groups suggests a common ceiling to antipsychotic efficacy.

AB - We compared symptom severity and quality of life (QOL) in schizophrenic patients adequately treated with typical antipsychotics (TAP) or clozapine (CZP). Groups did not differ in symptom severity or QOL. Clozapine caused fewer extrapyramidal symptoms. Negative and extrapyramidal symptoms predicted QOL. Similar outcome in both groups suggests a common ceiling to antipsychotic efficacy.

KW - Negative symptoms

KW - Parkinsonism

KW - Treatment outcome

UR - https://www.scopus.com/pages/publications/14644409711

UR - https://www.scopus.com/pages/publications/14644409711#tab=citedBy

U2 - 10.1016/j.psychres.2004.10.009

DO - 10.1016/j.psychres.2004.10.009

M3 - Article

C2 - 15741003

AN - SCOPUS:14644409711

SN - 0165-1781

VL - 133

SP - 277

EP - 280

JO - Psychiatry Research

JF - Psychiatry Research

IS - 2-3

ER -

Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this